Javascript must be enabled to continue!
Perioperative Anaesthetic Management in Emery-dreifuss Muscular Dystrophy: A Narrative Review
View through CrossRef
Emery-Dreifuss Muscular Dystrophy (EDMD) is a very rare but also clinically important laminopathy that is accompanied by early contractures, weakness of the humeroperoneal muscles and progressive cardiac involvement such as conduction abnormalities, atrial arrhythmias, and dilated cardiomyopathy. These multisystem characteristics present special perioperative problems in EDMD, and thus, EDMD is a high-risk condition for anaesthesiologists. This is a narrative review summarising the existing evidence, also highlighting the overall picture of perioperative considerations in EDMD in the light of preoperative optimisation, intraoperative monitoring, anaesthetic pharmacology and postoperative care. Preoperative evaluation of EDMD requires meticulous cardiac assessment with the help of ECG, echocardiography, Holter monitoring, as well as pacemaker/Implantable CardioverterDefibrillator (ICD) interrogation, alongside respiratory evaluation, which proves beneficial for restrictive physiology. Intraoperatively, it is necessary to have rhythm surveillance, invasive haemodynamic surveillance, quantitative neuromuscular surveillance, and the presence of external pacing. Succinylcholine should not be used because of the risks of hyperkalemia and rhabdomyolysis, and the non depolarising agents also require careful titration. Total Intravenous Anaesthesia (TIVA) may be preferred over volatile anaesthetic agents in selected patients, and multimodal analgesia, which is safe. Despite the advantages of the regional and neuraxial practices like opioid sparing and cardiac stability, their implementation needs a thorough selection of patients and cardiac preparedness. In the postoperative period, the EDMD patients should be monitored at the ICU level to identify the arrhythmias, respiratory dysfunction, and delayed neuromuscular recovery. The present review highlights the need for adequately standardised protocols and future research to improve perioperative safety related to the management of EDMD patients.
JCDR Research and Publications
Title: Perioperative Anaesthetic Management in Emery-dreifuss Muscular Dystrophy: A Narrative Review
Description:
Emery-Dreifuss Muscular Dystrophy (EDMD) is a very rare but also clinically important laminopathy that is accompanied by early contractures, weakness of the humeroperoneal muscles and progressive cardiac involvement such as conduction abnormalities, atrial arrhythmias, and dilated cardiomyopathy.
These multisystem characteristics present special perioperative problems in EDMD, and thus, EDMD is a high-risk condition for anaesthesiologists.
This is a narrative review summarising the existing evidence, also highlighting the overall picture of perioperative considerations in EDMD in the light of preoperative optimisation, intraoperative monitoring, anaesthetic pharmacology and postoperative care.
Preoperative evaluation of EDMD requires meticulous cardiac assessment with the help of ECG, echocardiography, Holter monitoring, as well as pacemaker/Implantable CardioverterDefibrillator (ICD) interrogation, alongside respiratory evaluation, which proves beneficial for restrictive physiology.
Intraoperatively, it is necessary to have rhythm surveillance, invasive haemodynamic surveillance, quantitative neuromuscular surveillance, and the presence of external pacing.
Succinylcholine should not be used because of the risks of hyperkalemia and rhabdomyolysis, and the non depolarising agents also require careful titration.
Total Intravenous Anaesthesia (TIVA) may be preferred over volatile anaesthetic agents in selected patients, and multimodal analgesia, which is safe.
Despite the advantages of the regional and neuraxial practices like opioid sparing and cardiac stability, their implementation needs a thorough selection of patients and cardiac preparedness.
In the postoperative period, the EDMD patients should be monitored at the ICU level to identify the arrhythmias, respiratory dysfunction, and delayed neuromuscular recovery.
The present review highlights the need for adequately standardised protocols and future research to improve perioperative safety related to the management of EDMD patients.
Related Results
Emery–Dreifuss muscular dystrophy
Emery–Dreifuss muscular dystrophy
Abstract
dystrophy (EMD) is an inherited disorder characterized by early onset contractures, progressive weakness in humero-peroneal muscles, and car- diomyopathy wi...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Ma...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background:
Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an ...
Challenges in developing gene therapy against Duchenne muscular dystrophy
Challenges in developing gene therapy against Duchenne muscular dystrophy
Duchenne muscular dystrophy is a progressive X-linked recessive neuromuscular disorder resulting from pathogenic mutations in the DMD gene, which codes dystrophin. It is one of the...
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Background
Cardiomyopathy is a leading cause of mortality among Duchenne muscular dystrophy patients and lacks effective therapies. Phosphodiesterase type 5 is ...
Advanced Physiotherapy Intervention for Muscular Dystrophy
Advanced Physiotherapy Intervention for Muscular Dystrophy
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over ...
Purine nucleoside use as surrogate markers of cerebral ischaemia during local and general anaesthetic carotid endarterectomy
Purine nucleoside use as surrogate markers of cerebral ischaemia during local and general anaesthetic carotid endarterectomy
Objectives:
In periods of cerebral ischaemia, adenosine triphosphate is metabolised, leading to accumulation of adenosine inosine and hypoxanthine. These can be...
Emery-Dreifuss syndrome.
Emery-Dreifuss syndrome.
Emery-Dreifuss muscular dystrophy is characterised by the triad of (1) early contractures of the elbows, Achilles tendons, and postcervical muscles; (2) slowly progressive muscle w...

